ClinConnect ClinConnect Logo
Search / Trial NCT06226532

Effect of Lidocaine Sprayed for Attenuating Hemodynamic Response During Laryngoscopy and Intubation

Launched by KHON KAEN UNIVERSITY · Jan 23, 2024

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Lidocaine Laryngoscopy And Intubation Hemodynamics Neurosurgery

ClinConnect Summary

This clinical trial is looking at how effective a medication called lidocaine is when sprayed directly into the throat area (laryngeal inlet) compared to lidocaine given through an IV (intravenous) line. The goal is to see which method better helps control heart rate and blood pressure during procedures where a tube is placed into the windpipe (intubation) in patients having brain surgery under general anesthesia. Researchers want to find out if the spray method is better at keeping these vital signs steady during the process.

To participate in this study, individuals need to be between 18 and 65 years old and in generally good health (classified as ASA I-II). However, those with certain conditions, such as allergies to lidocaine, difficult airways, or specific underlying health issues (like heart disease or severe kidney problems), will not be eligible. Participants will be randomly assigned to receive either the lidocaine spray or the IV lidocaine, and they can expect to be monitored closely during their procedure to see how well their body responds to each treatment method.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age 18-65 years old
  • 2. American Society of Anesthesiologists (ASA) physical status classification I-II
  • Exclusion Criteria:
  • 1. History of lidocaine allergy
  • 2. Predicted difficult airways
  • 3. Body mass index \> 35 kilograms per meter squared
  • 4. Risk aspiration
  • 5. Baseline hemodynamic instability; heart rate \< 50 bpm, heart rate \> 120 bpm, blood pressure \< 90/60 mmHg, blood pressure \> 160/90 mmHg
  • 6. Underlying disease: epilepsy, cardiovascular disease, heart failure, impaired cardiac function, severe renal dysfunction, impaired hepatic function, peripheral vascular disease
  • 7. Pregnancy
  • 8. Cerebral aneurysm, Arteriovenous malformation, Tumor size \> 4 centimeters, Brain herniation

About Khon Kaen University

Khon Kaen University is a leading research institution in Thailand, dedicated to advancing medical science and improving healthcare outcomes through innovative clinical trials. With a commitment to ethical research practices and community health, the university collaborates with various national and international partners to conduct studies across diverse fields, including public health, pharmaceuticals, and medical devices. By leveraging its multidisciplinary expertise and state-of-the-art facilities, Khon Kaen University aims to contribute valuable insights and evidence-based solutions that address pressing health challenges both locally and globally.

Locations

Nai Muang, Khonkaen, Thailand

Patients applied

0 patients applied

Trial Officials

Nattawadee Phokaw, MD

Principal Investigator

Department of anesthesiologist, Faculty of Medicine, Khon Kaen University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported